Ascendis Health

ASCENDIS PLANS TO SELL NON-CORE ASSETS IN SOUTH AFRICA

Johannesburg – Ascendis Health, the South African-based international healthcare company, today announced the planned disposal of smaller local non-core businesses as part of a strategic business review.

June 25, 2018

MEDIA RELEASE – 25 June 2018 The strategic review, initiated by new CEO Thomas Thomsen on his appointment in March this year, is aimed at creating a sustainable market position for Ascendis, accelerating organic growth, improving cash generation and enhancing profitability. The outcome of the strategic review and the new strategic focus of Ascendis will […]

ASCENDIS HEALTH FIRST HEALTHCARE COMPANY TO LIST ON A2X MARKETS

Ascendis Health is the first healthcare company in South Africa to secure a secondary listing on the A2X Markets (A2X) stock exchange.

May 24, 2018

Ascendis Health CEO Thomas Thomsen said: “Ascendis Health is pleased to complement its primary listing on the JSE with a new and secondary listing on A2X. This will offer investors the option to now trade Ascendis Health shares on either the JSE or A2X.” A2X is a licensed stock exchange which began trading in October […]

ASCENDIS PROFIT UP 28% AS HALF YEAR REVENUE TOPS R4 BILLION

57% of earnings generated outside South Africa

March 2, 2018

MEDIA RELEASE 1 March 2018 Johannesburg – Ascendis Health today reported a 27% increase in revenue to R4 billion for the six months to December 2017, driven by the strong performance of the group’s international operations which grew revenue by 50% to R1.9 billion. The health and care brands group increased operating profit for the […]

ASCENDIS HEALTH APPOINTS THOMAS THOMSEN AS NEW CHIEF EXECUTIVE

Johannesburg – JSE-listed health and care group Ascendis Health today announced the appointment of Thomas Thomsen as chief executive officer with effect from 1 March 2018.

February 27, 2018

MEDIA RELEASE 27 February 2018 Johannesburg – JSE-listed health and care group Ascendis Health today announced the appointment of Thomas Thomsen as chief executive officer with effect from 1 March 2018. London-based Thomsen (48) is currently the chief operating officer of Ascendis. He will succeed Dr Karsten Wellner (57) who has been the CEO of […]

ASCENDIS HEALTH FORTIFIES ITS INTERNATIONAL AND LOCAL POSITIONING WITH ANNOUNCEMENT OF STRATEGIC ACQUISITIONS.

Ascendis Health recently declared the acquisitions of Sunwave Pharma SRL and NHP Natural Health Pharma Ltd unconditional, together with Cipla Agrimed Proprietary Limited and Cipla Vet Proprietary Limited.

June 8, 2017

MEDIA RELEASE 05 June 2017 Ascendis Health recently declared the acquisitions of Sunwave Pharma SRL and NHP Natural Health Pharma Ltd unconditional, together with Cipla Agrimed Proprietary Limited and Cipla Vet Proprietary Limited. In early March Ascendis – the fast growing JSE-listed heath and care brands group – proposed acquiring the Eastern European company, Sunwave […]